1. Home
  2. OMCL vs EVO Comparison

OMCL vs EVO Comparison

Compare OMCL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • EVO
  • Stock Information
  • Founded
  • OMCL 1992
  • EVO 1993
  • Country
  • OMCL United States
  • EVO Germany
  • Employees
  • OMCL N/A
  • EVO N/A
  • Industry
  • OMCL Computer Manufacturing
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMCL Technology
  • EVO Health Care
  • Exchange
  • OMCL Nasdaq
  • EVO Nasdaq
  • Market Cap
  • OMCL 1.4B
  • EVO 1.2B
  • IPO Year
  • OMCL 2001
  • EVO 2021
  • Fundamental
  • Price
  • OMCL $30.26
  • EVO $3.94
  • Analyst Decision
  • OMCL Buy
  • EVO Strong Buy
  • Analyst Count
  • OMCL 7
  • EVO 1
  • Target Price
  • OMCL $46.71
  • EVO $7.00
  • AVG Volume (30 Days)
  • OMCL 455.5K
  • EVO 45.6K
  • Earning Date
  • OMCL 10-30-2025
  • EVO 11-05-2025
  • Dividend Yield
  • OMCL N/A
  • EVO N/A
  • EPS Growth
  • OMCL N/A
  • EVO N/A
  • EPS
  • OMCL 0.49
  • EVO N/A
  • Revenue
  • OMCL $1,149,529,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • OMCL $5.46
  • EVO N/A
  • Revenue Next Year
  • OMCL $3.75
  • EVO $10.78
  • P/E Ratio
  • OMCL $61.29
  • EVO N/A
  • Revenue Growth
  • OMCL 6.39
  • EVO N/A
  • 52 Week Low
  • OMCL $22.66
  • EVO $2.84
  • 52 Week High
  • OMCL $55.75
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 42.71
  • EVO 62.09
  • Support Level
  • OMCL $29.43
  • EVO $3.47
  • Resistance Level
  • OMCL $31.44
  • EVO $4.06
  • Average True Range (ATR)
  • OMCL 0.82
  • EVO 0.09
  • MACD
  • OMCL -0.10
  • EVO 0.05
  • Stochastic Oscillator
  • OMCL 26.55
  • EVO 79.10

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: